Sir Andrew Witty, Former CEO of GSK, Joins Synthego Advisory Board
REDWOOD CITY, CA--(Marketwired - Sep 20, 2017) - Synthego, a leading provider of genome engineering solutions, announces the appointment of Sir Andrew Witty, former CEO of GlaxoSmithKline (GSK) and Director at UnitedHealth Group, to the Synthego advisory …